ClinicalTrials.Veeva

Menu

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

G

Guoping Lu

Status

Enrolling

Conditions

Severe Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04923828
fdpicu-21

Details and patient eligibility

About

To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.

Full description

All patients admitted to the PICU during January 1, 2016 to December 31 2025 were included in the study, and all patients were followed up until death or PICU withdrawal. To establish the standardized Access database collected patients' general information, infection, PICU treatment, catheter, and short-term Prognosis and other clinical data.

Enrollment

2,000 estimated patients

Sex

All

Ages

1 month to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PICU patients with severe infection

Exclusion criteria

  • Non-infected patient

Trial contacts and locations

1

Loading...

Central trial contact

Guoping Lu, Doctor; Jing Liu, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems